- Home
- FREY vs SMTI Comparison
FREY vs SMTI Comparison
Compare FREY & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FREY
- SMTI
- Stock Information
- Founded
- FREY 2018
- SMTI 1982
- Country
- FREY Luxembourg
- SMTI United States
- Employees
- FREY N/A
- SMTI N/A
- Industry
- FREY Industrial Machinery/Components
- SMTI Medical/Dental Instruments
- Sector
- FREY Miscellaneous
- SMTI Health Care
- Exchange
- FREY Nasdaq
- SMTI Nasdaq
- Market Cap
- FREY 293.4M
- SMTI 288.2M
- IPO Year
- FREY N/A
- SMTI N/A
- Fundamental
- Price
- FREY $1.69
- SMTI $36.64
- Analyst Decision
- FREY
- SMTI Buy
- Analyst Count
- FREY 0
- SMTI 1
- Target Price
- FREY N/A
- SMTI $44.00
- AVG Volume (30 Days)
- FREY 3.6M
- SMTI 35.0K
- Earning Date
- FREY 11-06-2024
- SMTI 11-12-2024
- Dividend Yield
- FREY N/A
- SMTI N/A
- EPS Growth
- FREY N/A
- SMTI N/A
- EPS
- FREY N/A
- SMTI N/A
- Revenue
- FREY N/A
- SMTI $78,056,873.00
- Revenue This Year
- FREY N/A
- SMTI $29.95
- Revenue Next Year
- FREY $414.23
- SMTI $19.68
- P/E Ratio
- FREY N/A
- SMTI N/A
- Revenue Growth
- FREY N/A
- SMTI 24.66
- 52 Week Low
- FREY $0.91
- SMTI $26.00
- 52 Week High
- FREY $2.85
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- FREY 44.18
- SMTI 56.60
- Support Level
- FREY $2.03
- SMTI $34.50
- Resistance Level
- FREY $2.66
- SMTI $37.60
- Average True Range (ATR)
- FREY 0.20
- SMTI 1.88
- MACD
- FREY -0.10
- SMTI -0.23
- Stochastic Oscillator
- FREY 3.12
- SMTI 59.81
About FREY FREYR Battery Inc.
FREYR Battery Inc is an emerging producer of clean battery solutions for the planet. It designs and manufactures high-density and cost-competitive lithium-ion batteries with a reduced carbon footprint for the markets for electric mobility, stationary energy storage, and marine and aviation applications.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.